As of 2026-10-07, the Relative Valuation of IDEAYA Biosciences Inc (IDYA) is (30.10) USD. This relative valuation is based on P/E multiples. With the latest stock price at 36.63 USD, the upside of IDEAYA Biosciences Inc based on Relative Valuation is -182.2%.
The range of the Relative Valuation is (16.94) - (38.51) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.2x - 22.1x | 17.9x |
| Forward P/E multiples | 9.0x - 20.9x | 14.8x |
| Fair Price | (16.94) - (38.51) | (30.10) |
| Upside | -146.2% - -205.1% | -182.2% |
| Date | P/E |
| 2026-10-02 | -20.30 |
| 2026-10-01 | -20.54 |
| 2026-09-30 | -20.87 |
| 2026-09-29 | -20.57 |
| 2026-09-28 | -20.76 |
| 2026-09-25 | -19.93 |
| 2026-09-24 | -19.96 |
| 2026-09-23 | -20.35 |
| 2026-09-22 | -21.57 |
| 2026-09-21 | -21.11 |
| 2026-09-18 | -20.87 |
| 2026-09-17 | -20.97 |
| 2026-09-16 | -20.50 |
| 2026-09-15 | -20.46 |
| 2026-09-14 | -20.66 |
| 2026-09-11 | -20.42 |
| 2026-09-10 | -20.34 |
| 2026-09-09 | -20.83 |
| 2026-09-08 | -21.10 |
| 2026-09-04 | -21.65 |
| 2026-09-03 | -21.71 |
| 2026-09-02 | -21.82 |
| 2026-09-01 | -21.70 |
| 2026-08-31 | -21.78 |
| 2026-08-28 | -21.79 |
| 2026-08-27 | -22.69 |
| 2026-08-26 | -22.59 |
| 2026-08-25 | -23.08 |
| 2026-08-24 | -21.75 |
| 2026-08-21 | -21.55 |
| 2026-08-20 | -21.25 |
| 2026-08-19 | -21.12 |
| 2026-08-18 | -20.61 |
| 2026-08-17 | -19.85 |
| 2026-08-14 | -19.72 |
| 2026-08-13 | -19.93 |
| 2026-08-12 | -20.08 |
| 2026-08-11 | -20.01 |
| 2026-08-10 | -19.96 |
| 2026-08-07 | -20.11 |
| 2026-08-06 | -19.69 |
| 2026-08-05 | -19.58 |
| 2026-08-04 | -19.62 |
| 2026-08-03 | -19.23 |
| 2026-07-31 | -19.29 |
| 2026-07-30 | -19.77 |
| 2026-07-29 | -19.33 |
| 2026-07-28 | -19.64 |
| 2026-07-27 | -19.98 |
| 2026-07-24 | -19.23 |